ADDY Focus clinical research includes three clinical studies and a scientific review.

The Cleveland Clinic conducted the WGCP™ clinical study, rated one of America’s top hospitals by U.S. News and World Report. The Cleveland Clinic is a non-profit organization that does not endorse any particular product. They conduct clinical trials and report the facts and findings of the study. WGCP™ has been clinically shown to increase focus and concentration for 5-6 hours with zero side effects.

The study investigated the effects of WGCP™ on the ability of neurotypical individuals without diagnosed ADHD to exercise executive functions associated with sustained attention, spatial working memory, response inhibition, and impulsivity. These assist executive functions and remote cognitive activity similar to academic study.

To measure the effects of WGCP™ on core executive functions used in standard academic study, the Cleveland Clinic used the ADHD core battery of the Cambridge Neuropsychological Test Automated Battery (CANTAB).

The study used the withdrawal design to examine the differential effects of WGCP and placebo in neurotypical college-age adults ages 18 to 25.

ADDY™ Focus Stimulant is a formulation and patented process of RAW COFFEE CANEPHORA (WGCP™) that creates a naturally occurring slow release of essential acids, fiber, micronutrients, and natural caffeine fiber that cancels out all adverse side effects. Extracted stimulants pass through the blood-brain barrier too quickly, creating spikes, crashes, brain fog, and adrenal fatigue. WGCP™-ADDY™ stimulates the brain slowly, enabling a person’s dopamine to replenish naturally, preventing the dreaded crash that traditional stimulants create.